Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Health |
| Launch date | 23 Mar 2016 |
| Price currency | USD |
| Domicile | United States |
| Symbol | THISX |
| Manager & start date | Ziad Bakri 01 Apr 2016 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 14.64bn USD As of May 31 2024 |
| Share class size | 5.77bn USD As of May 31 2024 |
| Net expense ratio | 0.67% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 500,000.00 USD |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 39.83% | 33.65% | 0.00% | 33.65% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Eli Lilly and Co LLY:NYQ | +88.97% | 9.92% | |
| Aggregate Miscellaneous Equity | -- | 9.49% | |
| Unitedhealth Group Inc UNH:NYQ | +2.94% | 6.07% | |
| Intuitive Surgical Inc ISRG:NSQ | +32.44% | 4.13% | |
| Merck & Co Inc MRK:NYQ | +18.64% | 4.04% | |
| Per cent of portfolio in top 5 holdings: 33.65% |
Asset type
| US stock | 83.61% |
| Non-US stock | 6.58% |
| Cash | 0.13% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 9.68% |
Top 5 sectors
| Healthcare | 90.18% |
Top 5 regions
| United States | 83.61% |
| United Kingdom | 3.01% |
| Europe - ex Euro | 2.13% |
| Emerging Asia | 0.78% |
| Eurozone | 0.45% |
| Other | 0.20% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
